| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800077 | 重组抗EGFR全人源单克隆抗体注射液 | Injection | Biological Products(2) | New Drug Application | 2018-07-25 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2018-11-01 | view |